| Autor: |
Olga Kapustina, Polina Burmakina, Nina Gubina, Nikita Serov, Vladimir Vinogradov |
| Jazyk: |
angličtina |
| Rok vydání: |
2024 |
| Předmět: |
|
| Zdroj: |
Artificial Intelligence Chemistry, Vol 2, Iss 2, Pp 100072- (2024) |
| Druh dokumentu: |
article |
| ISSN: |
2949-7477 |
| DOI: |
10.1016/j.aichem.2024.100072 |
| Popis: |
Artificial intelligence has brought crucial changes to the whole field of natural sciences. Myriads of machine learning algorithms have been developed to facilitate the work of experimental scientists. Molecular property prediction and drug synthesis planning become routine tasks. Moreover, inverse design of compounds with tunable properties as well as on-the-fly autonomous process optimization and chemical space exploration became possible in silico. Affordable robotic platforms exist able to perform thousands of experiments every day, analyzing the results and tuning the protocols. Despite this, most of these developments get trapped at the stage of code or overlooked, limiting their use by experimental scientists. Meanwhile, visibility and the number of user-friendly tools and technologies available to date is too low to compensate for this fact, rendering the development of novel therapeutic compounds inefficient. In this Review, we set the goal to bridge the gap between modern technologies and experimental scientists to improve drug development efficacy. Here we survey advanced and easy-to-use technologies able to help medical chemists at every stage of their research, including those integrated in technological processes during COVID-19 pandemic motivated by the need for fast yet precise solutions. Moreover, we review how these technologies are integrated by industry and clinics to streamline drug development and production. These technologies already transform the current paradigm of scientific thinking and revolutionize not only medicinal chemistry, but the whole field of natural sciences. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
